Report #2850174

Received Jul 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NM
Recovered: Unknown
Vaccinated: May 28, 2025
Onset: May 28, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	—	—

Symptoms (2)

Incomplete course of vaccinationNo adverse event

Symptom narrative

Received First Dose And It Has Been More Than One Month; Initial report received on 03-Jul-2025. A pharmacist reported that a patient received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and has not received the next dose more than one month later. No medical history or concomitant medications were reported. On 28-May-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On 03-Jul-2025, 37 days after receiving the first dose of HEPLISAV-B, the reporter noted that more than one month had passed since the patient's first injection. No adverse reactions were reported. The reporter declined to provide further information. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.